These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9541726)

  • 21. The effect of pravastatin and atorvastatin on coenzyme Q10.
    Bleske BE; Willis RA; Anthony M; Casselberry N; Datwani M; Uhley VE; Secontine SG; Shea MJ
    Am Heart J; 2001 Aug; 142(2):E2. PubMed ID: 11479481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypolipidemic and body fat-lowering effects of Fatclean in rats fed a high-fat diet.
    Woo MN; Bok SH; Choi MS
    Food Chem Toxicol; 2009 Aug; 47(8):2076-82. PubMed ID: 19500640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pravastatin on plasma lipid concentrations in poloxamer 407-induced hyperlipidemic rats.
    Porter JA; Carter BL; Johnson TP; Palmer WK
    Pharmacotherapy; 1995; 15(1):92-8. PubMed ID: 7739951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet.
    Choi MS; Lee MK; Jung UJ; Kim HJ; Do GM; Park YB; Jeon SM
    Mol Nutr Food Res; 2009 Jun; 53(6):751-9. PubMed ID: 19205001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves in cholesterol-fed rats.
    Jemai H; Fki I; Bouaziz M; Bouallagui Z; El Feki A; Isoda H; Sayadi S
    J Agric Food Chem; 2008 Apr; 56(8):2630-6. PubMed ID: 18380465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The lipid-lowering and antioxidative effects of marine collagen peptides].
    Wang JB; Xie Y; Pei XR; Yang RY; Zhang ZF; Li Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Apr; 42(4):226-30. PubMed ID: 18763630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
    Vivekananthan K; Mehra MR; Uber PA; DeGruiter H; Lavie CJ; Milani RV
    J Assoc Physicians India; 2002 May; 50(5):682-4. PubMed ID: 12186124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.
    Ugawa T; Kakuta H; Moritani H; Matsuda K; Ishihara T; Yamaguchi M; Naganuma S; Iizumi Y; Shikama H
    Br J Pharmacol; 2000 Sep; 131(1):63-70. PubMed ID: 10960070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.
    Fujioka T; Nara F; Tsujita Y; Fukushige J; Fukami M; Kuroda M
    Biochim Biophys Acta; 1995 Jan; 1254(1):7-12. PubMed ID: 7811749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic.
    Eilat S; Oestraicher Y; Rabinkov A; Ohad D; Mirelman D; Battler A; Eldar M; Vered Z
    Coron Artery Dis; 1995 Dec; 6(12):985-90. PubMed ID: 8723021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pravastatin sodium on mevalonate metabolism in common marmosets.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Nezu H; Ito K; Kasanuki N; Koga T
    J Biochem; 2002 Sep; 132(3):395-400. PubMed ID: 12204108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of comparable serum cholesterol lowering effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A inhibitor, between once- and twice-daily treatment regimens in beagle dogs and rabbits.
    Fujioka T; Nara F; Shimada Y; Fukushige J; Shimotsu H; Shigehara E; Fukami M; Tsujita Y
    Jpn J Pharmacol; 1996 Apr; 70(4):329-35. PubMed ID: 8774761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
    Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
    Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipid-lowering effect of pravastatin on glomerulosclerosis protection and treatment].
    Lu Y; Li J; Zheng X
    Zhonghua Nei Ke Za Zhi; 1997 Apr; 36(4):242-5. PubMed ID: 10374286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.
    Williams JK; Sukhova GK; Herrington DM; Libby P
    J Am Coll Cardiol; 1998 Mar; 31(3):684-91. PubMed ID: 9502654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.